Jasper P. Luijkx
Heerlen, LI, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Lipid-lowering therapy omission at discharge and one-year outcomes after percutaneous coronary intervention: a real-world analysis of overall and elderly patients.
Journal: International journal of cardiology. Heart & vasculature
Published: April 22, 2026
Direct oral anticoagulation interruption versus continuation in patients undergoing elective invasive coronary angiography or percutaneous coronary intervention: design and rationale of the South Limburg Myocardial Infarction study group trial 2 (SLIM-2).
Journal: American heart journal
Published: February 12, 2026
Multifocal Fibromuscular Dysplasia in a Horseshoe Kidney: Coincidence or Consequence?
Journal: Cureus
Published: October 27, 2025
Design and rationale of the South-East Netherlands Heart Registry (ZON-HR).
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: January 15, 2025
The clinical value of bleeding risk stratification
Journal: Nederlands tijdschrift voor geneeskunde
Published: January 04, 2024
Platelet glycoprotein IIb/IIIa inhibitor tirofiban in clopidogrel-naïve patients undergoing elective percutaneous coronary intervention.
Journal: Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation
Published: July 24, 2023
Outcomes with P2Y12 inhibitor monotherapy after PCI according to bleeding risk: A Bayesian meta-analysis.
Journal: Cardiovascular revascularization medicine : including molecular interventions
Published: September 22, 2022
Short-term dual antiplatelet therapy in diabetic patients admitted for acute coronary syndrome treated with a new-generation drug-eluting stent.
Journal: Diabetes/metabolism research and reviews
Published: December 17, 2021
Showing 1-9 of 9
Last Updated: 09/26/2026